Linopin 40 mg injection

उत्पाद विवरण

1. Technical Specifications

2. Product Description

Lonopin 40 mg Injection contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) anticoagulant. It prevents formation of harmful blood clots by enhancing the activity of antithrombin III, which inhibits clotting factors such as Factor Xa and thrombin. It is widely prescribed for prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and clot-related complications during surgeries or immobility.

3. Product Highlights

4. Therapeutic Uses

• Prevention of Deep Vein Thrombosis (DVT) in patients undergoing orthopedic/abdominal surgery

• Treatment of DVT and Pulmonary Embolism (PE)

• Prevention of clotting in immobilized or bedridden patients

• Prevention of complications in patients with unstable angina or myocardial infarction

• Used in hemodialysis to prevent clot formation in extracorporeal circuits

5. Side Effects

Common:

• Pain, bruising, or redness at injection site

• Mild bleeding (nosebleeds, gums, bruises)

• Nausea, diarrhea

Serious (rare):

• Major bleeding (internal bleeding, black stools, blood in urine, coughing blood)

• Heparin-Induced Thrombocytopenia (HIT) low platelet count

• Severe allergic reactions (rash, swelling, difficulty breathing)

• Elevated liver enzymes

6. Precautions

• Use only under medical supervision

• Contraindicated in active bleeding or history of HIT

• Kidney impairment: dose adjustment may be required

• Regular monitoring of platelet count and coagulation profile is advised

• Avoid combining with other anticoagulants or NSAIDs unless prescribed (increases bleeding risk)

• Inform doctor before any planned surgery or dental work

• Use with caution during pregnancy and breastfeeding; only if benefits outweigh risks